You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,673,341


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,673,341 protect, and when does it expire?

Patent 8,673,341 protects DURYSTA and is included in one NDA.

This patent has eighty-two patent family members in twenty-three countries.

Summary for Patent: 8,673,341
Title:Intraocular pressure reduction with intracameral bimatoprost implants
Abstract: The present invention provides a method of treating an ocular condition in an eye of a patient, comprising the step of placing a biodegradable intraocular implant in an eye of the patient, the implant comprising a prostamide and a biodegradable polymer matrix that releases drug at a rate effective to sustain release of an amount of the prostamide from the implant to provide an amount of the prostamide effective to prevent or reduce a symptom of an ocular condition of the eye, wherein said ocular condition is elevated IOP and said implant is placed in an intracameral location to dilate the outflow channels of the eye emanating from Schlemm's Canal.
Inventor(s): Hughes; Patrick M. (Aliso Viejo, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:12/761,765
Patent Claim Types:
see list of patent claims
Use; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,673,341: A Comprehensive Analysis

Introduction

Patent 8,673,341, like any other patent, is a complex document that outlines the intellectual property rights of an invention. To fully grasp its implications, it is crucial to delve into the patent's scope, claims, and the broader patent landscape. This article will provide a detailed analysis of these aspects, helping business professionals and inventors navigate the intricacies of patent law.

What is Patent 8,673,341?

To begin, it is essential to identify the subject matter of the patent. However, without specific details from the query, we will use a general approach to analyze the components of a typical patent.

Patent Title and Abstract

The title and abstract of a patent provide a concise overview of the invention. These sections help in understanding the core idea and its application. For example, if the patent is related to a technological innovation, the title might reflect the specific technology, and the abstract would summarize its functionality and benefits.

Patent Claims

Types of Claims

Patent claims are the heart of any patent, as they define the scope of the invention and what is protected by the patent. There are two main types of claims: independent claims and dependent claims.

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. They are broad and encompass the core aspects of the invention[3].

Dependent Claims

Dependent claims, on the other hand, refer back to an independent claim and narrow down the scope by adding additional limitations. These claims are often used to protect specific embodiments or variations of the invention.

Claim Construction

The construction of claims is critical in determining the patent's scope. Courts often use the "plain and ordinary meaning" of the claim terms to interpret the claims. However, this can be complex, especially when dealing with abstract ideas or technological jargon. The "Alice test," for instance, is used to determine whether claims are directed to patent-eligible subject matter, particularly when it comes to abstract ideas[2].

Scope of the Patent

Patent Scope Metrics

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Broad vs. Narrow Claims

Broad claims cover a wider range of applications and are often more desirable but also risk being deemed overly broad or invalid. Narrow claims, while more specific, may offer stronger protection but limit the invention's applicability.

Patent Landscape

Historical Context

Understanding the historical context of patents in the United States can provide valuable insights. For instance, early patents from 1790 to 1836, known as "X" patents, were not numbered but are now retrospectively numbered for easier reference[1].

Current Search Tools

Modern patent searching is facilitated by advanced tools such as the USPTO's Patent Public Search, Global Dossier, and the Common Citation Document (CCD). These tools allow for comprehensive searches of prior art, patent families, and citation data, which are essential for determining the novelty and non-obviousness of an invention[4].

Global Integration

The global patent system is increasingly integrated, with services like the Global Dossier providing access to file histories and related applications from participating IP offices. This integration helps in assessing the global landscape of a patent and potential international implications[4].

Legal Considerations

Patent Eligibility

Patent eligibility is a critical legal consideration. Section 101 of the Patent Act specifies that only new and useful processes, machines, manufactures, or compositions of matter can be patented. The Supreme Court has established exceptions, such as laws of nature, natural phenomena, and abstract ideas, which are not patentable[2].

Litigation and Enforcement

Patent litigation, as seen in cases like Contour IP Holding LLC v. GoPro, Inc., highlights the importance of claim construction and patent eligibility. Courts use specific tests, such as the Alice test, to determine whether patent claims are valid and enforceable[2].

Practical Implications

Innovation and Licensing

The scope and claims of a patent significantly impact innovation and licensing. Overly broad patents can stifle innovation by increasing licensing and litigation costs, while well-defined patents can encourage innovation by providing clear boundaries[3].

Examination Process

The patent examination process also plays a crucial role. Research indicates that the examination process tends to narrow the scope of patent claims, which can affect the patent's validity and enforceability[3].

Key Takeaways

  • Patent Claims: Independent and dependent claims define the scope of the invention.
  • Scope Metrics: Independent claim length and count are key metrics for measuring patent scope.
  • Legal Considerations: Patent eligibility and claim construction are critical for determining the validity of a patent.
  • Global Integration: Modern tools facilitate global patent searches and integration.
  • Practical Implications: The scope and claims of a patent impact innovation, licensing, and litigation.

FAQs

What are the different types of patent claims?

Patent claims can be categorized into independent claims, which stand alone and define the invention, and dependent claims, which refer back to an independent claim and narrow down the scope.

How is the scope of a patent measured?

The scope of a patent can be measured using metrics such as independent claim length and independent claim count. These metrics help in assessing the breadth and specificity of the patent.

What is the Alice test in patent law?

The Alice test is a two-step test developed by the Supreme Court to determine whether patent claims are directed to patent-eligible subject matter, particularly when dealing with abstract ideas.

What tools are available for searching patents?

Tools such as the USPTO's Patent Public Search, Global Dossier, and the Common Citation Document (CCD) are available for comprehensive patent searches.

Why is patent eligibility important?

Patent eligibility is crucial because it determines whether an invention can be patented. It ensures that only new and useful processes, machines, manufactures, or compositions of matter are protected by patents.

Sources

  1. NYPL Libguides: How to Search for an Historical U.S. Patent.
  2. CAFC: Contour IP Holding LLC v. GoPro, Inc.
  3. SSRN: Patent Claims and Patent Scope.
  4. USPTO: Search for patents.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,673,341

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Abbvie DURYSTA bimatoprost IMPLANT;OPHTHALMIC 211911-001 Mar 4, 2020 RX Yes Yes 8,673,341 ⤷  Subscribe REDUCTION OF INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH OPEN ANGLE GLAUCOMA(OAG) OR OCULAR HYPERTENSION (OHT) WITH A BIODEGRADABLE BIMATOPROST IMPLANT ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,673,341

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria E397934 ⤷  Subscribe
Australia 2005244203 ⤷  Subscribe
Australia 2007223057 ⤷  Subscribe
Australia 2011239642 ⤷  Subscribe
Brazil 112012026535 ⤷  Subscribe
Brazil PI0510311 ⤷  Subscribe
Brazil PI0708622 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.